Almirall, S.A. (ALM.MC)
EUR 8.31
(1.03%)
EUR 8.31
(1.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -5.26 Million EUR | 3.27% |
| 2022 | 46.86 Million EUR | -55.52% |
| 2021 | 105.37 Million EUR | 14.17% |
| 2020 | 92.29 Million EUR | -38.43% |
| 2019 | 149.91 Million EUR | 72.33% |
| 2018 | 86.99 Million EUR | 128.06% |
| 2017 | -310.01 Million EUR | -377.78% |
| 2016 | 111.6 Million EUR | -33.68% |
| 2015 | 168.27 Million EUR | -66.99% |
| 2014 | 509.75 Million EUR | 704.32% |
| 2013 | -84.35 Million EUR | -232.94% |
| 2012 | 63.45 Million EUR | -17.92% |
| 2011 | 77.3 Million EUR | -49.93% |
| 2010 | 154.4 Million EUR | -13.79% |
| 2009 | 179.1 Million EUR | -80.16% |
| 2008 | 902.8 Million EUR | 155.6% |
| 2007 | 353.21 Million EUR | 164.17% |
| 2006 | 133.7 Million EUR | 7.67% |
| 2005 | 124.18 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 34.67 Million EUR | 442.15% |
| 2024 Q1 | -15.5 Million EUR | -473.13% |
| 2023 Q1 | 16.4 Million EUR | 1.31% |
| 2023 Q3 | -38.87 Million EUR | -183.23% |
| 2023 FY | 48.4 Million EUR | 3.27% |
| 2023 Q4 | 4.15 Million EUR | 110.69% |
| 2023 Q2 | 46.71 Million EUR | 184.82% |
| 2022 Q2 | 46.63 Million EUR | 74.0% |
| 2022 Q1 | 26.8 Million EUR | 132.4% |
| 2022 FY | 46.86 Million EUR | -55.52% |
| 2022 Q4 | 16.18 Million EUR | 0.0% |
| 2021 Q1 | 38.2 Million EUR | 6214.05% |
| 2021 Q3 | 121.67 Million EUR | 180.15% |
| 2021 Q2 | 43.43 Million EUR | 13.69% |
| 2021 FY | 105.37 Million EUR | 14.17% |
| 2021 Q4 | -82.72 Million EUR | -167.99% |
| 2020 Q2 | -14 Thousand EUR | -100.02% |
| 2020 Q3 | 11.88 Million EUR | 84992.86% |
| 2020 FY | 92.29 Million EUR | -38.43% |
| 2020 Q4 | 605 Thousand EUR | -94.91% |
| 2020 Q1 | 57.2 Million EUR | -17.72% |
| 2019 FY | 149.91 Million EUR | 72.33% |
| 2019 Q4 | 69.51 Million EUR | 1247.89% |
| 2019 Q2 | 58.05 Million EUR | 45.87% |
| 2019 Q3 | -6.05 Million EUR | -110.43% |
| 2019 Q1 | 39.8 Million EUR | -40.48% |
| 2018 Q1 | 25.3 Million EUR | -65.77% |
| 2018 FY | 86.99 Million EUR | 128.06% |
| 2018 Q2 | 40.26 Million EUR | 59.14% |
| 2018 Q4 | 66.86 Million EUR | 420.52% |
| 2018 Q3 | -20.86 Million EUR | -151.82% |
| 2017 Q4 | 73.9 Million EUR | 700.87% |
| 2017 FY | -310.01 Million EUR | -377.78% |
| 2017 Q2 | 11.26 Million EUR | 278.87% |
| 2017 Q3 | -12.3 Million EUR | -209.15% |
| 2017 Q1 | -6.3 Million EUR | -113.59% |
| 2016 Q4 | 46.37 Million EUR | 203.1% |
| 2016 FY | 111.6 Million EUR | -33.68% |
| 2016 Q1 | 16.3 Million EUR | -80.0% |
| 2016 Q3 | 15.3 Million EUR | -74.04% |
| 2016 Q2 | 58.94 Million EUR | 261.61% |
| 2015 Q4 | 81.51 Million EUR | 320.96% |
| 2015 Q3 | -36.89 Million EUR | -159.32% |
| 2015 Q2 | 62.19 Million EUR | 261.58% |
| 2015 FY | 168.27 Million EUR | -66.99% |
| 2015 Q1 | 17.2 Million EUR | -96.95% |
| 2014 Q1 | -5.8 Million EUR | -105.34% |
| 2014 FY | 509.75 Million EUR | 704.32% |
| 2014 Q4 | 564.59 Million EUR | 4986.47% |
| 2014 Q3 | 11.1 Million EUR | 310.07% |
| 2014 Q2 | -5.28 Million EUR | 8.9% |
| 2013 Q3 | -33.6 Million EUR | -204.27% |
| 2013 FY | -84.35 Million EUR | -232.94% |
| 2013 Q1 | -24.5 Million EUR | 71.69% |
| 2013 Q4 | 108.71 Million EUR | 423.55% |
| 2013 Q2 | 32.22 Million EUR | 231.53% |
| 2012 Q3 | -45.6 Million EUR | -2041.25% |
| 2012 Q1 | 14.9 Million EUR | 162.61% |
| 2012 FY | 63.45 Million EUR | -17.92% |
| 2012 Q2 | 2.34 Million EUR | -84.23% |
| 2012 Q4 | -86.55 Million EUR | -89.8% |
| 2011 Q2 | 42.2 Million EUR | 11.35% |
| 2011 Q1 | 37.9 Million EUR | 398.68% |
| 2011 Q3 | 21 Million EUR | -50.24% |
| 2011 Q4 | -23.79 Million EUR | -213.32% |
| 2011 FY | 77.3 Million EUR | -49.93% |
| 2010 Q4 | 7.6 Million EUR | -81.95% |
| 2010 FY | 154.4 Million EUR | -13.79% |
| 2010 Q1 | 62.9 Million EUR | 276.65% |
| 2010 Q2 | 41.8 Million EUR | -33.55% |
| 2010 Q3 | 42.1 Million EUR | 0.72% |
| 2009 Q4 | 16.7 Million EUR | -67.0% |
| 2009 Q1 | 63.3 Million EUR | 0.0% |
| 2009 FY | 179.1 Million EUR | -80.16% |
| 2009 Q3 | 50.6 Million EUR | 4.33% |
| 2009 Q2 | 48.5 Million EUR | -23.38% |
| 2008 FY | 902.8 Million EUR | 155.6% |
| 2007 FY | 353.21 Million EUR | 164.17% |
| 2006 FY | 133.7 Million EUR | 7.67% |
| 2005 FY | 124.18 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Faes Farma, S.A. | 185.28 Million EUR | 102.841% |
| Laboratorio Reig Jofre, S.A. | 10.51 Million EUR | 150.086% |